Nivolumab: Does the Extended CheckMate-274 Results Prove It’s the Ultimate for MIBC? ASCO GU 2025 ASCO GU 3 Mins Read Extended CheckMate-274 Results Show Continued Benefit With Nivolumab in MIBCDate: February 14, 2025Author: Dr. Matthew I. Milowsky, MD, FASCO, University…
NATERA GALAXY Study Links ctDNA Status to Survival & Treatment Response ESMO 2024 Colorectal 4 Mins Read The GALAXY Study has provided compelling data that highlights the predictive value of circulating tumor DNA (ctDNA) status in colorectal…
